EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Gut-on-a-Chip for Infectious Diseases: A Pathogen-Centric Review of Model Selection and Validation

Shujun Nie, Zhifeng Li, Zilin Zhang, Boyang Song, Jun Ouyang, Yuan Xu, Huadong Zhang, Zaozao Chen, Zhongze Gu, Wanjiang Gu

BME Frontiers · 2026-01-01 · 7

DOI: 10.34133/bmef.0336 ↗
AbstractBibliografische Angaben

Abstract

Gut-on-a-chip systems are microfluidic, 3-dimensional (3D) in vitro platforms designed to recapitulate selected intestinal features, including epithelial polarity, fluid flow, peristalsis-like deformation, mucus formation, oxygen gradients, and, in some designs, epithelial–endothelial or host–microbiome interactions. Rather than treating increasing structural complexity as an inherent surrogate for biological fidelity, this review evaluates gut-on-a-chip models according to the infectious-disease question being addressed, the specific biological functions reproduced, the measurable infection endpoints, and the level of experimental or translational validation. We synthesize evidence across bacterial, viral, and parasitic infections and compare the relative maturity of these applications. Bacterial models currently represent the most mature evidence base, whereas fungal infections are considered where direct gut-on-a-chip evidence remains limited. We further examine host–microbiome interactions and gut–organ-axis platforms only when they provide a mechanistic or translational perspective relevant to infection. Four major evidence gaps are identified: limited head-to-head benchmarking against established models or clinical observations, incomplete standardization of chip and infection parameters, limited culture duration and microbial complexity in many systems, and relatively sparse infection-specific applications of artificial intelligence. Finally, we propose a validation-oriented framework linking pathogen, biological question, required chip feature, measurable endpoint, and evidence level, and we clarify the current regulatory position of new approach methodologies (NAMs).

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →